Publications

5674 Results

Smoking, sex and non-small cell lung cancer: examination of steroid hormone receptors in lung tumor tissue in SWOG S0424

Authors
TD Cheng;A Darke;M Redman;G Zirpoli;W Davis;R Ondracek;W Bshara;AR Omilian;R Kratzke;JR Molina;JM Kolesar;Y Chen;R MacRae;J Moon;P Mack;D Gandara;K Kelly;R Santella;K Albain;C Ambrosone
Journal / Conference
Journal of the National Cancer Institute Jul 1;110(7):734-742; Jan 13. doi: 10.1093/jnci/djx260. [Epub ahead of print]
Year
2018
Research Committee(s)
Lung
PMID
PMID29346580
PMC
PMC6037104
Study Number(s)
S0424

Phase 2 study of RCHOP, radioimmunotherapy and maintenance rituximab in untreated follicular lymphoma: SWOG S0801

Authors
P Barr;H Li;WR Burack;M Leblanc;S Smith;AK Gopal;JD Floyd;D Persky;O Press;RI Fisher;JW Friedberg
Journal / Conference
Lancet Haematology Mar;5(3):e102-e108; 2018 Jan 25 [Epub ahead of print]
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID29396094
PMC
PMC6501182
Study Number(s)
S0801

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with doxorubicin-based adjuvant chemotherapy (SWOG S9313)

Authors
P Sharma;W Barlow;A Godwin;H Pathak;K Isakova;K Timms;A Hartman;R Wenstrup;H Linden;D Tripathy;G Hortobagyi;DF Hayes
Journal / Conference
Annals of Oncology Mar 1;29(3):654-660; Dec 23 [Epub ahead of print] 2017
Year
2018
Research Committee(s)
Breast
PMID
PMID29293876
PMC
PMC4076636
Study Number(s)
SWOG-9313

Quality of life (QOL) during treatment with chemohormonal therapy: analysis of ECOG 3805 chemohormonal androgen ablation randomized trial in prostate cancer (CHAARTED)

Authors
A Morgans;Y Chen;C Sweeney;D Jarrad;E Plimack;B Gartrell;M Carducci;M Hussain;J Garcia;D Cella;R DiPaola;L Patrick-Miller
Journal / Conference
Journal of Clinical Oncology, Apr 10;36(11):1088-1095; Mar 9 [Epub ahead of print]
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29522362
PMC
PMC5891128
Study Number(s)
CTSU/E3805

Two-Year Trends Of Taxane-Induced Neuropathy In Women Enrolled In A Randomized Trial Of Acetyl-L-Carnitine (SWOG S0715)

Authors
DL Hershman;JM Unger;K Crew;C Till;H Greenlee;L Minasian;C Moinpour;DL Lew;L Fehrenbacher;JL Wade;S-F Wong;M Fisch;KS Albain
Journal / Conference
Journal of the National Cancer Institute Jun 1;110(6):669-676; 2018 Jan 18. doi: 10.1093/jnci/djx259. [Epub ahead of print]
Year
2018
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID29361042
PMC
PMC6005110
Study Number(s)
S0715

Drug interaction screening in SWOG Clinical Trials

Authors
D Hertz;R Siden;J Modlin;M Gabel;S-F Wong
Journal / Conference
American Journal of Health-System Pharmacy May 15;75(10):607-612
Year
2018
Research Committee(s)
Multiple sites
PMID
PMID29748299
PMC
PMC6685422

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Authors
JC Byrd;AS Ruppert;NA Heerema;AE Halvorson;M Boyd;E Hoke;MR Smith;JE Godwin;S Couban;TA Fehniger;M Thirman;M Tallman;F Appelbaum;RM Stone;S Robinson;JE Chang;SJ Mandrekar;RA Larson
Journal / Conference
Blood Advances, Jul 24;2(14):1705-1718
Year
2018
Research Committee(s)
Leukemia
PMID
PMID30030269
PMC
PMC6058242
Study Number(s)
C10404

Immediate post TURBT instillation of gemcitabine vs saline for suspected low grade bladder cancer: SWOG S0337

Authors
E Messing;C Tangen;SP Lerner;D Sahasrabudhe;T Koppie;DP Wood;PC Mack;R Svatek;C Evans;K Hafez;D Culkin;T Brand;L Karsh;J Holzbeierlein;SS Wilson;G Wu;M Plets;NJ Vogelzang;IM Thompson
Journal / Conference
JAMA May 8;319(18):1880-1888
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29801011
PMC
PMC6583489
Study Number(s)
S0337

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: results from SWOG S0421

Authors
PN Lara;M Plets;C Tangen;E Gertz;N Vogelzang;M Hussain;P Twardowski;M Garzotto;JP Monk;M Carducci;A Goldkorn;PC Mack;DI Quinn;IM Thompson;M Van Loan
Journal / Conference
Cancer Treatment and Research Communications 16:18-23
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID31298998
PMC
PMC6628720
Study Number(s)
S0421

Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 trial

Authors
CE Kyriakopoulos;Y Chen;M Carducci;G Liu;DF Jarrard;M Eisenberger;Y Wong;N Hahn;M Koli;M Cooney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R DiPaola;C Sweeney
Journal / Conference
Journal of Clinical Oncology Apr 10;36(11):1080-1087; Jan 31:JCO2017753657 [Epub ahead of print]
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29384722
PMC
PMC5891129
Study Number(s)
CTSU/E3805